Bob Pragada’s Post

RESISTANCE IS NOT AN OPTION

A new paper from another succesfull European Lead Factory - SciLifeLab collaboration. Read more on the discovery of novel inhibitors of insulin-regulated aminopeptidase (IRAP) to serve as potential future cognitive enhancers. Innovative Health Initiative (IHI), #DrugDiscovery

🌟 Unlock Your Laboratory's Full Potential! 🌟 In the dynamic realm of scientific research and development, the maturity of your lab isn't just a status – it's a beacon guiding you towards excellence. 🚀 We understand the pivotal role that operational efficiency, technological sophistication, and readiness to tackle both current and future challenges play in your success. That's why we're excited to introduce our Lab Maturity Assessment! A tailored questionnaire crafted to help you shed light on your laboratory's capabilities. 🧬 By dedicating a few moments to answer the questions, you will gain a detailed analysis of your lab's current operational state📊 and insights into how your lab's maturity level stacks up against peers🔍. Whether you're aiming to benchmark your lab's performance or looking for ways to stride ahead, this is your first step towards realizing your lab's untapped potential. Click here to start your Lab Maturity Assessment journey today: https://lnkd.in/e8faeDEU #LabExcellence #InnovationInScience #FutureReady

Check out the latest Outcome Capital's index tracker, transaction highlights, and strategic analysis by Outcome's #lifesciences deal team. - #radiopharmaceuticals continue to garner attention with third deal in six months - Rise in mid-cap acquisitions highlights active deployment of cash in an effort to refresh #biopharma pipelines - #medtech companies merge as a strategy to gain access to public markets

🌟 Unlock Your Laboratory's Full Potential! 🌟 In the dynamic realm of scientific research and development, the maturity of your lab isn't just a status – it's a beacon guiding you towards excellence. 🚀 We understand the pivotal role that operational efficiency, technological sophistication, and readiness to tackle both current and future challenges play in your success. That's why we're excited to introduce our Lab Maturity Assessment! A tailored questionnaire crafted to help you shed light on your laboratory's capabilities. 🧬 By dedicating a few moments to answer the questions, you will gain a detailed analysis of your lab's current operational state📊 and insights into how your lab's maturity level stacks up against peers🔍. Whether you're aiming to benchmark your lab's performance or looking for ways to stride ahead, this is your first step toward realizing your lab's untapped potential. Click here to start your Lab Maturity Assessment journey today: https://lnkd.in/eUtTTJMi #LabExcellence #InnovationInScience #FutureReady

🌟 Unlock Your Laboratory's Full Potential! 🌟 In the dynamic realm of scientific research and development, the maturity of your lab isn't just a status – it's a beacon guiding you towards excellence. 🚀 We understand the pivotal role that operational efficiency, technological sophistication, and readiness to tackle both current and future challenges play in your success. That's why we're excited to introduce our Lab Maturity Assessment! A tailored questionnaire crafted to help you shed light on your laboratory's capabilities. 🧬 By dedicating a few moments to answer the questions, you will gain a detailed analysis of your lab's current operational state📊 and insights into how your lab's maturity level stacks up against peers🔍. Whether you're aiming to benchmark your lab's performance or looking for ways to stride ahead, this is your first step towards realizing your lab's untapped potential. Click here to start your Lab Maturity Assessment journey today: https://lnkd.in/eUtTTJMi #LabExcellence #InnovationInScience #FutureReady

Innovative! Let's make it happen because Type II Diabetes is a huge cost burden to the global economy despite it being a reversible disease. Insulin Resistance Syndrome, and it's consequences, is possibly THE biggest killer of human beings, right Tony Bartlett ? I tried to Educate UK Physicians when discussing and laughing "Avandia" (Rosiglitazone) in the UK, but they weren't quite ready for the truth, and we're entrenched in prescribing sulphasalazine, which forces the Pancreas to work much harder, thereby destroying the Islets of Langerhans, and stopping natural process of Insulin production in the human body. This was was very frustrating even in 2001, especially as we has NHS Pharmaceutical Advisors and N.I.C.E (National Institute for Climical Excellence) trying to stop Rosiglitazone from being prescribed as it was more expensive than the cheap "crap" that didn't work! Hey ho, that's the NHS National Institute for Curbing Expenditure for you !? Since the 1990's N.I.C.E have banned or restricted many groundbreaking medicines being available on NHS prescription, leading to a bigger financial burden on the NHS, human suffering and patients early death! Such is the ignorance. Quite ironic really don't you think?

In our discussions with senior industry leaders managing laboratory ecosystems, a recurring issue is the lack of clarity about their current state. Understanding this maturity level is pivotal for initiating and planning a successful transformation journey. We're excited to introduce a streamlined maturity assessment tool that provides substantial value to our clients. It enables them to benchmark their 'laboratories ecosystem' against industry benchmarks derived from in-depth research conducted by our Capgemini Research Institute. A brilliant showcase of Capgemini's thought leadership, backed by its unmatched execution capabilities. It was an honor to collaborate with the think tank (Brian, Matt, Srini, and Amit) in developing the framework. #LabMaturity, #LabBenchmark, #CapgeminiInsights, #AssessmentFramework Brian Eden,Matthew Thompson,Amit Kakatkar,Justin Melnick, Gert-Jan Schoppert, Srinivas Sarangapurkar

HGF Partners Dan Woollaston and Andrew Wells are attending the BioInfect Conference on the 8th of February at The Spine in Liverpool. The theme for this year's conference is Antimicrobial Resistance: the Next Pandemic, where speakers will examine issues surrounding the increasing threat of AMR and how it can be tackled, such as: ✔ The need for greater innovation and investment in new drug development ✔ The effectiveness of current and proposed reimbursement models ✔ The efficacy of new and alternative treatments and ✔ How organisations, stakeholders, and policymakers can work together more effectively to combat this global issue. Find out more here: https://lnkd.in/e727TAEJ Bionow #BioInfect2024 #Chemistry #AntiMicrobialResistance #BioNow #HGFEurope

Learn how you can avoid common obstacles when setting up your new lab. Attend our Knowledge Culture Webinar to accelerate your discovery ... from the start!